Citations

Clear

13 citation(s) found for "Thomas, Timothy K".

Volume electron microscopy reveals heterogeneity of the hemostatic response in veins and arteries
Tomaiuolo, Maurizio , Roberts, Meghan E., Severa, Jenna Ruth, Mansi, C., Mathers, Brenna B.Y., Mannix, Anna , Christensen, Trace , Sinno, Talid , Severa, Jenna R , Christensen, Trace A , Sinno, Talid , Mansi, Christopher D., Brass, Lawrence F. , Stalker, Timothy J.

Mayo Clinic

Blood Advances | February 12, 2026 | Volume: 10 | Issue: 9 | Pages: 3143-3153

10.1182/bloodadvances.2025017110 | PMID 41678831 Get It

Abstract Intravital imaging studies have provided insights into the spatial and temporal variations of platelet activation and thrombin generation that occur during hemostasis; however, these studies are generally limited to small vessels due to the practical limitations of imaging in thicker tissues. Recent advances in cleared tissue fluorescence imaging as well as volume electron microscopy (vEM) coupled with machine learning–based image segmentation provide an opportunity for analysis of the 3-dimensional structure of complex tissues. We utilized these technologies to examine hemostatic plugs from murine jugular veins and carotid arteries to investigate the spatial distribution of platelet activation and biochemical responses in these disparate physiologic contexts. Both venous and arterial hemostatic plugs had a heterogeneous structure with regions of sparsely and densely packed platelets. Despite similar injury sizes, arterial hemostatic plugs were at least an order of magnitude larger than venous plugs. The difference in plug size was primarily due to a 19-fold increase in the population of densely packed platelets in the extravascular compartment. Venous plugs displayed significant platelet aggregation extending into the vessel lumen and developed distinctive fibrin and red blood cell–filled cavities. Complementary fluorescence microscopy revealed that platelet activation was spatially heterogeneous in both contexts, with α-granule secretion and phosphatidylserine exposure confined to specific microenvironments, highlighting tightly regulated thrombin activity. Overall, our findings reveal both conserved and distinct mechanisms of hemostatic thrombus formation in different physiologic contexts. They also demonstrate the power of vEM coupled with machine learning–based image segmentation for the quantitative analysis of large imaging data sets from complex tissues.
Placental hypoxia and oxidative stress responses to smokeless tobacco use in Alaska Native participants in the MAW study
Kennedy, Katherine M. , Wallace, Jessica G. , Thomas, Timothy K., Murphy, Neil J. , Hughes, Christine A. , Holloway, Alison C. , Sloboda, Deborah M. , Patten, Christi A. , Holloway, Alison C , Koller, Kathryn R. , Flanagan, Christie A.

Mayo Clinic

Canadian Journal of Physiology and Pharmacology | January 7, 2026 | Volume: 104 | Issue: No issue available | Pages: 1-7

10.1139/cjpp-2025-0271 | PMID 41499767 Get It

Cigarette smoking is associated with numerous adverse pregnancy outcomes, due in part to polycyclic aromatic hydrocarbons and free radicals produced by combustion. Less is known about the impact of smokeless tobacco (ST) use during pregnancy. Alaska Native women report higher rates of cigarette and ST use during pregnancy than non-Native women. We investigated oxidative stress and hypoxia pathways in term placentae from Alaska Native women who did (commercial or iqmik; n = 10) or did not ( n = 18) use ST during pregnancy. Despite substantial maternal exposure to nicotine, placentae of women who used ST had similar mRNA levels of antioxidant enzymes and markers of hypoxia compared to those who did not use tobacco. Although mRNA levels of angiogenesis markers vegf and vegfr2 were similar between groups, vegfr1 mRNA levels are increased in placentae of women using ST compared to women who did not use tobacco. Together these results suggest that, while ST use may not have as significant an effect on oxidative stress pathways in the placenta as cigarette smoking, an effect is present. It is not clear what this limited effect may have on the developing fetus.
Adapting a Financial Incentives Intervention for Smoking Cessation With Alaska Native Families: Phase 1 Qualitative Research to Inform the Aniqsaaq (To Breathe) Study
Tranby, Brianna , Young, Antonia M , King, Diane K. , Lee, Flora R., Sabaque, Corinna, Prochaska, Judith J. , Decker, Paul A. , McDonell, Michael G. , Stillwater, Barbara , Thomas, Timothy K. , Sinicrope, Pamela S. , Tranby, Brianna N , Sabaque, Corinna V, Thomas, Timothy K , Patten, Christi , Koller, Kathryn R. , Borah, Bijan J. , Decker, Paul A. , Patten, Christi A.

Mayo Clinic

Nicotine and Tobacco Research | April 20, 2024 | Volume: 26 | Issue: 10 | Pages: 1377-1384

10.1093/ntr/ntae092 | PMID 38642396 Get It

Abstract Introduction Alaska Native and American Indian (ANAI) peoples in Alaska currently experience a disproportionate burden of morbidity and mortality from tobacco cigarette use. Financial incentives for smoking cessation are evidence-based, but a family-level incentive structure has not been evaluated. We used a community-based participatory research and qualitative approach to culturally adapt a smoking cessation intervention with ANAI families. Aims and Methods We conducted individual, semistructured telephone interviews with 12 ANAI adults who smoke, 12 adult family members, and 13 Alaska Tribal Health System stakeholders statewide between November 2022 and March 2023. Through content analysis, we explored intervention receptivity, incentive preferences, culturally aligned recruitment and intervention messaging, and future implementation needs. Results Participants were receptive to the intervention. Involving a family member was viewed as novel and aligned with ANAI cultural values of commitment to community and familial interdependence. Major themes included choosing a family member who is supportive and understanding, keeping materials positive and encouraging, and offering cash and noncash incentives for family members to choose (eg, fuel, groceries, activities). Participants indicated that messaging should emphasize family collaboration and that cessation resources and support tips should be provided. Stakeholders also reinforced that program materials should encourage the use of other existing evidence-based cessation therapies (eg, nicotine replacement, counseling). Conclusions Adaptations, grounded in ANAI cultural strengths, were made to the intervention and recruitment materials based on participant feedback. Next steps include a beta-test for feasibility and a randomized controlled trial for efficacy. Implications This is the first study to design and adapt a financial incentives intervention promoting smoking cessation among ANAI peoples and the first to involve the family system. Feedback from this formative work was used to develop a meaningful family-level incentive structure with ANAI people who smoke and family members and ensure intervention messaging is supportive and culturally aligned. The results provide qualitative knowledge that can inform future family-based interventions with ANAI communities, including our planned randomized controlled trial of the intervention.
Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Shields, Peter G. , Balis, David S. , Davis, James M. , Edmondson, Donna, Feliciano, Joy, Hudmon, Karen Suchanek , Jaklitsch, Michael T. , McCarthy, Danielle E. , Ong, Michael , Prochaska, Judith J. , Sandoval, Argelia, Sheffer, Christine E. , Spencer, Sharon, Tindle, Hilary A. , Tong, Elisa K. , Triplette, Matthew , Urbanic, James J., Videtic, Gregory M.M. , Whitlock, C. Will, McCullough, Beth, Darlow, Susan, Warner, David, Thomas, Timothy K , Sheffer, Christine E , Davis, James M , Bierut, Laura Jean , Arenberg, Douglas A. , Cinciripini, Paul M , Hitsman, Brian L. , Leone, Frank T. , Ling, Pamela May , Park, Elyse R , Studts, Jamie L. , Tanvetyanon, Tawee , Warner, David O.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | March 10, 2023 | Volume: 21 | Issue: 3 | Pages: 297-322

10.6004/jnccn.2023.0013 | PMID 36898367 Get It

Although the harmful effects of smoking after a cancer diagnosis have been clearly demonstrated, many patients continue to smoke cigarettes during treatment and beyond. The NCCN Guidelines for Smoking Cessation emphasize the importance of smoking cessation in all patients with cancer and seek to establish evidence-based recommendations tailored to the unique needs and concerns of patients with cancer. The recommendations contained herein describe interventions for cessation of all combustible tobacco products (eg, cigarettes, cigars, hookah), including smokeless tobacco products. However, recommendations are based on studies of cigarette smoking. The NCCN Smoking Cessation Panel recommends that treatment plans for all patients with cancer who smoke include the following 3 tenets that should be done concurrently: (1) evidence-based motivational strategies and behavior therapy (counseling), which can be brief; (2) evidence-based pharmacotherapy; and (3) close follow-up with retreatment as needed.
Facebook Intervention to Connect Alaska Native People With Resources and Support to Quit Smoking: CAN Quit Pilot Randomized Controlled Trial
Patten, Christi A. , Koller, Kathryn R. , Prochaska, Judith J. , Resnicow, Ken , Decker, Paul A. , Hughes, Christine A. , Merritt, Zoe T , McConnell, Clara R , Thomas, Timothy K. , Sinicrope, Pamela S. , Thomas, Timothy K , Young, Colleen , Patten, Christi , Koller, Kathryn , Decker, Paul A. , Huang, Ming

Mayo Clinic

Nicotine & Tobacco Research | September 21, 2022 | Volume: 25 | Issue: 4 | Pages: 803-813

10.1093/ntr/ntac221 | PMID 36130170 Get It

AbstractIntroductionThere is some evidence that social media interventions can promote smoking cessation. This randomized controlled pilot study is the first to evaluate the feasibility and potential efficacy of a Facebook smoking cessation intervention among Alaska Native (AN) adults.Aims and MethodsRecruitment and data collection occurred from December 2019 to March 2021. Participants were recruited statewide in Alaska using Facebook advertisements with a targeted sample of 60 enrolled. Participants were stratified by gender, age, and rural or urban residence and randomly assigned to receive referral resources on evidence-based cessation treatments (EBCTs) (control, n = 30) or these resources plus a 3-month, closed (private), culturally tailored, Facebook group (intervention, n = 31) that connected participants to EBCT resources and was moderated by two Alaska Native Trained Tobacco Specialists. Assessments were conducted online post-randomization at 1, 3, and 6 months. Outcomes were feasibility (recruitment, retention, and intervention engagement), self-reported use of EBCTs, and biochemically confirmed seven-day point-prevalence smoking abstinence.ResultsOf intervention participants, 90% engaged (eg posted, commented) more than once. Study retention was 57% at 6 months (no group differences). The proportion utilizing EBCTs was about double for intervention compared with the control group participants at 3 and 6 months. Smoking abstinence was higher for intervention than control participants at 3 months (6.5% vs. 0%, p = .16) but comparable at 6 months (6.4% vs. 6.7%, p = .97).ConclusionsWhile additional research is needed to promote long-term cessation, this pilot trial supports recruitment feasibility during the Coronavirus Disease 2019 (COVID-19) pandemic, consumer uptake, and a signal for intervention efficacy on the uptake of cessation treatment and short-term smoking abstinence.ImplicationsThis study is the first evaluation of a social media intervention for smoking cessation among Indigenous people. We learned that statewide Facebook recruitment of AN adults who smoke was feasible and there was a signal for the efficacy of a Facebook intervention on the uptake of EBCT and short-term (3 months) biochemically verified smoking abstinence. Clinically, social media platforms may complement current care models by connecting AN individuals and others living in hard-to-reach communities to cessation treatment resources.
The Effect of Tobacco Use on the Expression of Placental Transporters in Alaska Native Women
McColl, Eliza R. , Kwok, Jacinda, Benowitz, Neal L. , Hughes, Christine A. , Thomas, Timothy K. , Hiratsuka, Vanessa Y. , Tyndale, Rachel F. , Patten, Christi A. , Tyndale, Rachel F , Hiratsuka, Vanessa , Koller, Kathryn R. , Flanagan, Christie A. , Piquette‐Miller, Micheline

Mayo Clinic

Clinical Pharmacology & Therapeutics | September 2, 2022 | Volume: 113 | Issue: 3 | Pages: 634-642

10.1002/cpt.2737 | PMID 36053152 Get It

Prenatal tobacco use among Alaska Native (AN) women has decreased substantially over the past two decades. Previous research suggests that providing AN women with feedback regarding fetal exposure to tobacco may further promote cessation. Transporters in the placenta regulate fetal exposure to nutrients and xenobiotics, including compounds associated with tobacco use. We examined whether prenatal tobacco use impacts transporter expression in the placenta, and whether this is influenced by fetal sex, degree of tobacco exposure, or transporter genotype. At delivery, we obtained placental samples from AN research participants who smoked cigarettes, used commercial chew or iqmik (oral tobacco), or did not use tobacco during pregnancy. Transporter expression was evaluated using qRT‐PCR and Western blotting and tested for correlations between transcript levels and urinary biomarkers of tobacco use. The impact of BCRP/ABCG2 and OATP2B1/SLCO2B1 genotypes on protein expression was also examined. Oral tobacco use was associated with decreased P‐gp and increased MRP1, MRP3, LAT1, and PMAT mRNA expression. Transcript levels of multiple transporters significantly correlated with tobacco biomarkers in maternal and fetal urine. In women carrying male fetuses, both smoking and oral tobacco were associated with decreased P‐gp. Oral tobacco was also associated with decreased LAT1 in women carrying female fetuses. BCRP and OATP2B1 genotypes did not appear to impact protein expression. In conclusion, prenatal tobacco use is associated with altered expression of multiple placental transporters which differs by fetal sex. As transcript levels of multiple transporters were significantly correlated with tobacco use biomarkers, eliminating prenatal tobacco use should alleviate these changes.
Developing a Social Media Intervention to Connect Alaska Native People Who Smoke with Resources and Support to Quit Smoking: The Connecting Alaska Native Quit Study
Merculieff, Zoe T., Hughes, Christine A. , Bock, Martha J. , Decker, Paul A. , Resnicow, Ken , Meade, Crystal D , McConnell, Clara R , Prochaska, Judith J. , Thomas, Timothy K., Sinicrope, Pamela S. , Thomas, Timothy K , Patten, Christi A. , Koller, Kathryn R. , Decker, Paul A. , Flanagan, Christie A.

Mayo Clinic

Nicotine & Tobacco Research | December 1, 2020 | Volume: 23 | Issue: 6 | Pages: 1002-1009

10.1093/ntr/ntaa253 | PMID 33674856 Get It

Abstract Background Face-to-face tobacco cessation has had limited reach and efficacy in Alaska Native (AN) communities. We describe our two-phased approach to develop content for Connecting Alaska Native People to Quit Smoking, a Facebook group intervention to reduce barriers to evidence-based smoking cessation treatment for AN people in Alaska. Methods Phase 1 included semi-structured telephone interviews with 30 AN people who smoke and ten stakeholders. They provided feedback on existing content from the Centers for Disease Control and Prevention Tips campaign and AN digital stories. Phase 2 included an online survey with a new group of 40 AN smokers who provided feedback on existing content via a measure of perceived effectiveness and cultural relevance. Results Phase I results revealed participants evaluated content based upon story strength, relevance to AN culture, emotional appeal, relatability to AN people, and favorite video. No single posting was rated highly across all themes. All perceived effectiveness (PE) and cultural relevance median scores fell between 3.5 and 4.4 (range 1–5). PE scores varied across participant demographic groups. Conclusions Content embodying characteristics perceived to be most appealing, effective, and culturally relevant were selected for the private Facebook group content library with refinements made to incorporate images of AN people engaged in AN activities. PE scores indicate a need for a wide variety of content that moderators could pull from when conducting the intervention. Implications Social media content targeting specific population sectors, such as American Indian/AN people for tobacco cessation needs to be culturally tailored. Our approach provides a model others can follow to determine what is appealing, relevant, and effective messaging. Clinical Trial Registration NCT 03645941.
Postpartum Tobacco Use and Perceived Stress among Alaska Native Women: MAW Phase 4 Study
Koller, Kathryn R. , Hiratsuka, Vanessa Y. , Merritt, Zoe T , Sapp, Flora, Meade, Crystal D , Hughes, Christine A. , Decker, Paul A. , Murphy, Neil J. , Thomas, Timothy K. , Patten, Christi A. , Koller, Kathryn , Hiratsuka, Vanessa , Flanagan, Christie A. , Decker, Paul A.

Mayo Clinic

International Journal of Environmental Research and Public Health | August 21, 2019 | Volume: 16 | Issue: 17 | Pages: 3024

10.3390/ijerph16173024 | PMID 31438550 Get It

Prior research explored reasons for tobacco use among pregnant Alaska Native (AN) women but did not address the postpartum period. This study followed up with AN women one to three years postpartum who had participated in a prenatal smoking cessation intervention study (Motivate Alaska Women (MAW) Phase 3) and had consented to be re-contacted for future studies. Of 47 eligible women, 32 (68%) participated. A semi-structured phone interview was conducted a mean of 2.0 years after delivery (range 1.6–2.8). Measures assessed self-reported tobacco use status in the 12 months after delivery, at 12 months postpartum, and at the time of the interview; reasons for maintaining abstinence, continued use, or relapse; and included the Perceived Stress Scale (PSS) and Negative Affect (NA) scale. Content analysis was used to generate themes from open-ended response items. Tobacco use was reported by 23 women (72%) at delivery, 30 (94%) within the 12 months after delivery, 27 (84%) at 12 months postpartum, and 29 (91%) at the time of the interview. Among nine women not using tobacco at delivery, seven (78%) relapsed during the 12 months after delivery. Of the 29 current tobacco users, 28 (97%) smoked cigarettes. Twenty-seven participants (84%) reported stress and 15 (52%) indicated addiction as reasons for continuing, starting, or resuming tobacco use. Types of stressors were related to parenting and traumatic experiences. Among current tobacco users, mean NA score (18.7) was significantly higher (p = 0.01) than the normative mean (14.8), but no differences were detected for PSS score. In this sample of AN women, postpartum tobacco use was highly prevalent, and stress was a primary reason that women endorsed for using tobacco. These preliminary results have several practice and research implications for exploring ways to support non-tobacco use among postpartum AN women.
Definition of Successful Infection Management and Guidelines for Reporting of Outcomes After Surgical Treatment of Periprosthetic Joint Infection
Fillingham, Yale A. , Valle, Craig J. Della , Suleiman, Linda I. , Springer, Bryan D. , Gehrke, Thorsten , Bini, Stefano A. , Segreti, John , Chen, Antonia F. , Goswami, Karan , Tan, Timothy L. , Shohat, Noam , Díaz-Ledezma, Claudio , Schwartz, Adam J. , Gehrke, Thorsten A. , Parvizi, Javad , Chen, Antonia F

Mayo Clinic

Journal of Bone and Joint Surgery | July 18, 2019 | Volume: 101 | Issue: 14 | Pages: e69

10.2106/jbjs.19.00062 | PMID 31318814 Get It

2018 International Consensus Meeting on Musculoskeletal Infection: Research Priorities from the General Assembly Questions
Schwarz, Edward M. , Gehrke, Thorsten , Aiyer, Amiethab A. , Battenberg, Andrew K. , Brown, Scot , Callaghan, John J. , Egol, Kenneth A. , Garrigues, Grant E. , Ghert, Michelle , Goswami, Karan , Hammound, Sommer, McLaren, A. C. , Mont, Michael A. , Namdari, Surena , Obremskey, William T. , O’Toole, Robert V. , Raikin, Steven M. , Restrepo, Camilo , Ricciardi, Benjamin F. , Saeed, Kordo , Shohat, Noam , Tan, Timothy L. , Thirukumaran, Caroline P. , Winters, Brian S., Sanchez-Sotelo, Joaquin, Schwarz, Edward M , Parvizi, Javad , Gehrke, Thorsten A. , Çıtak, Mustafa , Green, Andrew , Kates, Stephen L. , Sánchez‐Sotelo, Joaquín

Mayo Clinic

Journal of Orthopaedic Research | April 12, 2019 | Volume: 37 | Issue: 5 | Pages: 997-1006

10.1002/jor.24293 | PMID 30977537 Get It

ABSTRACT Musculoskeletal infections (MSKI) remain the bane of orthopedic surgery, and result in grievous illness and inordinate costs that threaten healthcare systems. As prevention, diagnosis, and treatment has remained largely unchanged over the last 50 years, a 2nd International Consensus Meeting on Musculoskeletal Infection (ICM 2018, https://icmphilly.com ) was completed. Questions pertaining to all areas of MSKI were extensively researched to prepare recommendations, which were discussed and voted on by the delegates using the Delphi methodology. The questions, including the General Assembly (GA) results, have been published ( GA questions ). However, as critical outcomes include: (i) incidence and cost data that substantiate the problems, and (ii) establishment of research priorities; an ICM 2018 research workgroup (RW) was assembled to accomplish these tasks. Here, we present the result of the RW consensus on the current and projected incidence of infection, and the costs per patient, for all orthopedic subspecialties, which range from 0.1% to 30%, and $17,000 to $150,000. The RW also identified the most important research questions. The Delphi methodology was utilized to initially derive four objective criteria to define a subset of the 164 GA questions that are high priority for future research. Thirty‐eight questions (23% of all GA questions) achieved the requisite > 70% agreement vote, and are highlighted in this Consensus article within six thematic categories: acute versus chronic infection, host immunity, antibiotics, diagnosis, research caveats, and modifiable factors. Finally, the RW emphasizes that without appropriate funding to address these high priority research questions, a 3rd ICM on MSKI to address similar issues at greater cost is inevitable.